ONTARGET: use of ramipril, telmisartan, or both in patients with high cardiovascular risks.
Lee
HoWon
H
Division of Endocrinology, Department of Medicine, State University of New York-Downstate Medical Center, Kings County Hospital, Brooklyn, NY 11203, USA.
Makaryus
Amgad N
AN
McFarlane
Samy I
SI